NHI-2
NHI-2 is a selective LDHA inhibitor (IC50 = 14.7 μM) that disrupts cancer cell metabolism, exhibiting potent antiproliferative effects in vitro and suppressing tumor growth in murine melanoma models, making it a valuable tool for oncology and cancer metabolism research.
Product Specifications
CAS Number
1269802-97-2
Product Name Alternative
NHI 2, NHI2
Field of Research
Cell Biology
Purity
>98%
Bioactivity
LDHA inhibitor
Form
Powder
Solubility
Soluble in DMSO (up to 25 mg/ml) .
Smiles
C (F) (F) (F) C1=C2C (N (O) C (C (OC) =O) =C2) =CC (=C1) C3=CC=CC=C3
Molecular Formula
C17H12F3NO3
Molecular Weight
335.28
Storage Conditions
-20°C
Notes
For research use only.
Other Product Names
Methyl 1-Hydroxy-6-phenyl-4-trifluoromethyl-1H-indole-2-carboxylate
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1007130-01 0.02 mg (E-Coli)
Recombinant Shewanella amazonensis Histidine--tRNA ligase (hisS)
Sign In for Pricing
View Details MBS1007130-02 0.02 mg (Yeast)
Recombinant Shewanella amazonensis Histidine--tRNA ligase (hisS)
Sign In for Pricing
View Details MBS1007130-03 0.1 mg (E-Coli)
Recombinant Shewanella amazonensis Histidine--tRNA ligase (hisS)
Sign In for Pricing
View Details MBS1007130-04 0.1 mg (Yeast)
Recombinant Shewanella amazonensis Histidine--tRNA ligase (hisS)
Sign In for Pricing
View Details MBS1007130-05 0.02 mg (Baculovirus)
Recombinant Shewanella amazonensis Histidine--tRNA ligase (hisS)
Sign In for Pricing
View Details